GB0812641D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0812641D0
GB0812641D0 GBGB0812641.9A GB0812641A GB0812641D0 GB 0812641 D0 GB0812641 D0 GB 0812641D0 GB 0812641 A GB0812641 A GB 0812641A GB 0812641 D0 GB0812641 D0 GB 0812641D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0812641.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prosidion Ltd
Original Assignee
Prosidion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prosidion Ltd filed Critical Prosidion Ltd
Priority to GBGB0812641.9A priority Critical patent/GB0812641D0/en
Publication of GB0812641D0 publication Critical patent/GB0812641D0/en
Priority to PCT/GB2009/050828 priority patent/WO2010004345A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0812641.9A 2008-07-10 2008-07-10 Compounds Ceased GB0812641D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0812641.9A GB0812641D0 (en) 2008-07-10 2008-07-10 Compounds
PCT/GB2009/050828 WO2010004345A1 (en) 2008-07-10 2009-07-10 Piperidinyl gpcr agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0812641.9A GB0812641D0 (en) 2008-07-10 2008-07-10 Compounds

Publications (1)

Publication Number Publication Date
GB0812641D0 true GB0812641D0 (en) 2008-08-20

Family

ID=39722067

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0812641.9A Ceased GB0812641D0 (en) 2008-07-10 2008-07-10 Compounds

Country Status (2)

Country Link
GB (1) GB0812641D0 (en)
WO (1) WO2010004345A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0904287D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB0904284D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB0904285D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
EA201200046A1 (en) 2009-06-24 2012-08-30 Бёрингер Ингельхайм Интернациональ Гмбх NEW COMPOUNDS, PHARMACEUTICAL COMPOSITION AND RELATED METHODS
AR077214A1 (en) 2009-06-24 2011-08-10 Neurocrine Biosciences Inc NITROGEN HETEROCICLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP2013522279A (en) 2010-03-18 2013-06-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Combination of GPR119 agonist and DDP-IV inhibitor linagliptin for use in the treatment of diabetes and related conditions
GB201006167D0 (en) 2010-04-14 2010-05-26 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB201006166D0 (en) 2010-04-14 2010-05-26 Prosidion Ltd Compounds for the treatment of metabolic disorders
TW201209054A (en) 2010-05-28 2012-03-01 Prosidion Ltd Novel compounds
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
GB201114389D0 (en) 2011-08-22 2011-10-05 Prosidion Ltd Novel compounds
WO2012066077A1 (en) 2010-11-18 2012-05-24 Prosidion Limited 1,4 di substituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders
BR112013030472A2 (en) 2011-06-30 2019-09-24 Genentech Inc pharmaceutical formulation, article of manufacture and method
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP2014533700A (en) 2011-11-21 2014-12-15 ジェネンテック， インコーポレイテッド Purification of anti-c-MET antibody
EP3749305A1 (en) * 2018-02-05 2020-12-16 Université de Strasbourg Compounds and compositions for the treatment of pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2308840A1 (en) * 2005-06-30 2011-04-13 Prosidion Limited GPCR agonists
US20100048625A1 (en) * 2007-01-04 2010-02-25 Matthew Colin Thor Fyfe Piperidine gpcr agonists
PE20081659A1 (en) * 2007-01-04 2008-10-24 Prosidion Ltd GPCR AGONISTS

Also Published As

Publication number Publication date
WO2010004345A1 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
GB0807862D0 (en) Compounds
GB0812648D0 (en) Compounds
GB0812649D0 (en) Compounds
GB0812641D0 (en) Compounds
GB0804702D0 (en) Compounds
GB0809776D0 (en) Compounds
GB0807103D0 (en) Compounds
GB0800367D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0801265D0 (en) Compounds
GB0805815D0 (en) Compounds
GB0811029D0 (en) Compounds
GB0808471D0 (en) Inseticidal compounds
GB0808123D0 (en) Compounds
GB0808119D0 (en) Compounds
GB0807911D0 (en) Compounds
GB0809771D0 (en) Compounds
GB0807415D0 (en) Compounds
GB0810118D0 (en) Compounds
GB0810619D0 (en) Compounds
GB0807047D0 (en) Compounds
GB0806449D0 (en) Compounds
GB0806448D0 (en) Compounds
GB0806083D0 (en) Compounds
GB0805048D0 (en) Niovel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)